CHRS: Coherus BioSciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 259.24
Enterprise Value ($M) 629.72
Book Value ($M) -193.43
Book Value / Share -1.72
Price / Book -1.34
NCAV ($M) -314.66
NCAV / Share -2.79
Price / NCAV -0.82

Profitability (mra)
Return on Invested Capital (ROIC) -0.83
Return on Assets (ROA) -0.49
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.23
Current Ratio 3.00

Balance Sheet (mrq) ($M)
Current Assets 508.37
Assets 629.60
Liabilities 823.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 257.24
Operating Income -198.11
Net Income -237.89
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -174.88
Cash from Investing 144.64
Cash from Financing 69.60

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Alliancebernstein L.p. 0.10 -97.49
02-14 13G/A Citadel Advisors Llc 1.80
02-13 13G/A Vanguard Group Inc 9.30 78.09
01-24 13G/A BlackRock Inc. 10.80 3.68
01-22 13G/A State Street Corp 1.85 -69.58
12-07 13G/A Jpmorgan Chase & Co 0.10 -97.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 520,285 2,490,714 20.89
2024-03-26 703,361 3,064,907 22.95
2024-03-25 285,927 1,856,087 15.40
2024-03-22 569,855 2,085,061 27.33

(click for more detail)

Similar Companies
CARA – Cara Therapeutics, Inc. CARM – Carisma Therapeutics, Inc.
CGTX – Cognition Therapeutics, Inc. CLSD – Clearside Biomedical, Inc.
CMRX – Chimerix, Inc.


Financial data and stock pages provided by
Fintel.io